AMED Amedisys Inc.

Amedisys is Named One of the Most Responsible Companies of 2023 by Statista and Newsweek

Amedisys is Named One of the Most Responsible Companies of 2023 by Statista and Newsweek

BATON ROUGE, La. and NASHVILLE, Tenn., Dec. 08, 2022 (GLOBE NEWSWIRE) -- Amedisys is recognized as one of the most responsible companies in the nation, according to a report by Statista in the latest issue of Newsweek magazine. The recognition is based on key performance indicators derived from the company’s corporate social responsibility and sustainability report and includes performance in the areas of environment, social and corporate governance.

“At Amedisys, our goal is to be a good corporate citizen and to act responsibly in the way we treat our patients, our employees, our communities and the environment that we all share. We are honored to be recognized by Statista and Newsweek for these efforts,” said Paul Kusserow, Chairman and Chief Executive Officer. “Our commitment to social responsibility allows us to attract the best staff, provide high-quality services to patients, address climate change and drives our business forward.”

According to Amedisys’ Environmental, Social and Governance Report, the company is committed to:

  • developing a strong system of independent governance to ensure it meets the high standards expected of a leading healthcare company,
  • creating an open and inclusive place to work, with comprehensive benefits, personal and professional development and high clinical standards,
  • ensuring a diverse and inclusive workplace free of discrimination,
  • outperforming the industry in quality of patient care in all lines of business,
  • supporting employees and patients through the Amedisys Foundation,
  • quantifying the company’s environmental impact to develop meaningful strategies to help combat climate change and
  • achieving net-zero GHG emissions from its operations no later than 2050.

The final list recognizes the top 500 most responsible companies of 2023 in the United States, spanning 14 industries.

To learn more about Amedisys and its ESG strategy, please see its Corporate Sustainability Report

About Amedisys 

Amedisys, Inc. is a leading healthcare at home Company delivering personalized home health, hospice, personal care and high-acuity care services. Amedisys is focused on delivering the care that is best for our patients, whether that is home-based personal care; inpatient hospital, palliative, and skilled nursing facility (“SNF”) care in their homes; recovery and rehabilitation after an operation or injury; care focused on empowering them to manage a chronic disease; or hospice care at the end of life. More than 3,000 hospitals and 90,000 physicians nationwide have chosen Amedisys as a partner in post-acute care. Founded in 1982, headquartered in Baton Rouge, LA with an executive office in Nashville, TN, Amedisys is a publicly held company. With approximately 21,000 employees, in 547 care centers in 37 states, Amedisys is dedicated to delivering the highest quality of care to the doorsteps of more than 445,000 patients in need every year, performing more than 11.5 million visits annually. For more information about the Company, please visit: .

Contact:
Nick MuscatoKendra Kimmons
Amedisys, Inc.Amedisys, Inc.
Investor RelationsMedia Relations
615.928.5452225.299.3720
  


EN
08/12/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Amedisys Inc.

 PRESS RELEASE

Amedisys Reports First Quarter 2025 Financial Results

Amedisys Reports First Quarter 2025 Financial Results BATON ROUGE, La., April 23, 2025 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period ended March 31, 2025. Three-Month Periods Ended March 31, 2025 and 2024 Net service revenue increased $23.4 million to $594.8 million compared to $571.4 million in 2024.Net income attributable to Amedisys, Inc. of $61.0 million, which is inclusive of merger-related expenses totaling $16.8 million ($16.6 million, net of tax) and a $48.1 million gain on an equity method investment ($35.6 mi...

 PRESS RELEASE

Amedisys Reports Fourth Quarter and Year End 2024 Financial Results

Amedisys Reports Fourth Quarter and Year End 2024 Financial Results BATON ROUGE, La., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period and year ended December 31, 2024. Three-Month Periods Ended December 31, 2024 and 2023 Net service revenue increased $27.3 million to $598.1 million compared to $570.8 million in 2023.Net loss attributable to Amedisys, Inc. of $20.4 million, which is inclusive of merger-related expenses totaling $17.4 million ($15.9 million, net of tax) and a non-cash goodwill and other inta...

 PRESS RELEASE

Amedisys Honors 47 Employees With Annual Spirit of Excellence Award

Amedisys Honors 47 Employees With Annual Spirit of Excellence Award BATON ROUGE, La., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care services, has recognized 47 employees with the prestigious Spirit of Excellence Awards, one of the company’s highest honors. “Every day, our employees bring warmth, compassion and clinical expertise into the homes of our patients, offering the care they need in the place they most want to be,” said Richard Ashworth, President and Chief Executive Officer. “We are privileged to ...

 PRESS RELEASE

Amedisys Reports Third Quarter 2024 Financial Results

Amedisys Reports Third Quarter 2024 Financial Results BATON ROUGE, La., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and nine-month periods ended September 30, 2024. Three-Month Periods Ended September 30, 2024 and 2023 Net service revenue increased $31.5 million to $587.7 million compared to $556.2 million in 2023.Net income attributable to Amedisys, Inc. of $16.9 million, which is inclusive of merger-related expenses totaling $16.7 million ($16.7 million, net of tax) compared to net income attributable...

 PRESS RELEASE

Amedisys has earned the 2023 SHPBest™ Patient Satisfaction Awards

Amedisys has earned the 2023 SHPBest™ Patient Satisfaction Awards BATON ROUGE, La., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care in the home, has 92 home health and hospice care centers recognized by Strategic Healthcare Programs (SHP) for achieving the highest overall HHCAHPS patient satisfaction or CAHPS Hospice caregiver satisfaction scores of all eligible SHP clients in 2023. This includes 14 care centers awarded Premier Performer, ranking in the top 5%, and 78 care centers awarded Superior Performer,...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch